Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Debt (2018 - 2025)

Profound Medical has reported Non-Current Debt over the past 6 years, most recently at $4.5 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 53.86% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, up 53.86%, while the annual FY2025 figure was $4.5 million, 53.86% up from the prior year.
  • Non-Current Debt for Q4 2025 was $4.5 million at Profound Medical, up from $4.5 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $6.2 billion in Q1 2023 and troughed at $2.9 million in Q4 2024.
  • A 4-year average of $523.2 million and a median of $4.5 million in 2025 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: crashed 99.93% in 2024 and later skyrocketed 53.86% in 2025.
  • Year by year, Non-Current Debt stood at $6.7 million in 2022, then fell by 24.82% to $5.0 million in 2023, then tumbled by 41.52% to $2.9 million in 2024, then soared by 53.86% to $4.5 million in 2025.
  • Business Quant data shows Non-Current Debt for PROF at $4.5 million in Q4 2025, $4.5 million in Q2 2025, and $4.5 million in Q1 2025.